1. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999; 341:142–147.
2. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008; 358:1336–1345.
3. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease. Circulation 2005; 111:3316–3326.
4. Madhavan MV, Tarigopula M, Mintz GS, Maehara A, Stone GW, Ge´ne´reux P. Coronary artery calcification. J Am Coll Cardiol 2014; 63:1703 – 1714.
5. Owens DS, Katz R, Takasu J, Kronmal R, Budoff MJ, O’Brien KD. Incidence and progression of aortic valve calcium in the Multiethnic Study of Atherosclerosis (MESA). Am J Cardiol 2010; 105:701–708.
6. Kronmal RA, Mcclelland RL, Detrano R, Shea S, Lima JOA, Cushman M, et al. Risk factors for the progression of coronary artery calcification in asymptomatic subjects. Circulation 2007; 115:2722–2730.
7. Linefsky JP, O’Brien KD, Sachs M, Katz R, Eng J, Michos ED, et al. Serum phosphate is associated with aortic valve calcification in the Multiethnic Study of Atherosclerosis (MESA). Atherosclerosis 2014; 233:331–337.
8. Han D, Cordoso R, Whelton S, Rozanski A, Budoff MJ, Miedema MD, et al. Prognostic significance of aortic valve calcium in relation to coronary artery calcification for long-term, cause-specific mortality: results from the CAC Consortium. Eur Heart J 2020; 22:1257–1263.
9. Yang W-Y, Melgarejo JD, Thijs L, Zhang Z-Y, Boggia J, Wei F-F, et al. Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes. JAMA 2019; 322:409.
10. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control. Circulation 2016; 134:441–450.
11. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ ASH/ASPC/NMA/PCNA guideline for the prevention, detection, eval- uation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice. Hypertension 2018; 71:e13–e115.
12. Stergiou GS, Palatini P, Parati G, O’Brien E, Januszewicz A, Lurbe E, et al. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens 2021; 39:1293–1302.
13. Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res 2019; 42:1235–1481.
14. Banegas JR, Ruilope LM, De La Sierra A, Vinyoles E, Gorostidi M, De La Cruz JJ, et al. Relationship between clinic and ambulatory blood- pressure measurements and mortality. N Engl J Med 2018; 378:1509–1520.
15. Iwata S, Russo C, Jin Z, Schwartz JE, Homma S, Elkind MS, et al. Higher ambulatory blood pressure is associated with aortic valve calcification in the elderly: a population-based study. Hypertension 2013; 61:55–60.
16. Choi HY, Lee CJ, Lee JE, Yang HS, Kim HY, Park HC, et al. Loss of nighttime blood pressure dipping as a risk factor for coronary artery calcification in nondialysis chronic kidney disease. Medicine (Balti- more) 2017; 96:e7380.
17. Turner ST, Bielak LF, Narayana AK, Sheedy PF, Schwartz GL, Peyser PA. Ambulatory blood pressure and coronary artery calcification in middle-aged and younger adults. Am J Hypertens 2002; 15:518–524.
18. Zhang Y, Schwartz JE, Jaeger BC, An J, Bellows BK, Clark D, et al. Association between ambulatory blood pressure and coronary artery calcification: the JHS. Hypertension 2021; 77:1886–1894.
19. Cremer A, Doublet J, Boulestreau R, Gaudissard J, Tzourio C, Gosse P. Short-term blood pressure variability, arterial stiffness, and cardiovas- cular events: results from the Bordeaux cohort. J Hypertens 2021; 39:947–951.
20. Chowdhury EK, Wing LMH, Jennings GLR, Beilin LJ, Reid CM. Visit-to- visit (long-term) and ambulatory (short-term) blood pressure variabili- ty to predict mortality in an elderly hypertensive population. J Hyper- tens 2018; 36:1059–1067.
21. Verdecchia P, Angeli F, Gattobigio R, Rapicetta C, Reboldi G. Impact of blood pressure variability on cardiac and cerebrovascular complica- tions in hypertension. Am J Hypertens 2007; 20:154–161.
22. Ueshima H, Kadowaki T, Hisamatsu T, Fujiyoshi A, Miura K, Ohkubo T, et al. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian random- ization analysis in a general Japanese population. Atherosclerosis 2016; 246:141–147.
23. Hisamatsu T, Miura K, Fujiyoshi A, Kadota A, Miyagawa N, Satoh A, et al. Serum magnesium, phosphorus, and calcium levels and subclini- cal calcific aortic valve disease: a population-based study. Atheroscle- rosis 2018; 273:145–152.
24. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15:827–832.
25. Katz R, Wong ND, Kronmal R, Takasu J, Shavelle DM, Probstfield JL, et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis. Circulation 2006; 113:2113–2119.
26. Naschitz J, Gaitini L, Loewenstein L, Keren D, Zuckerman E, Tamir A, et al. In-field validation of automatic blood pressure measuring devi- ces. J Hum Hypertens 2000; 14:37–42.
27. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2006; 28:1462–1536.
28. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32:3–107.
29. Group JJW. Guidelines for the clinical use of 24 hour ambulatory blood pressure monitoring (ABPM) (JCS 2010) – digest version. Circ J 2012; 76:508–519.
30. Hisamatsu T, Ohkubo T, Hozawa A, Fujiyoshi A, Torii S, Segawa H, et al. Association of self-measured home, ambulatory, and strictly measured office blood pressure and their variability with intracranial arterial stenosis. J Hypertens 2021; 39:2030–2039.
31. Nakamura K, Kikuya M, Hara A, Hirose T, Obara T, Metoki H, et al. Validation of the FM-800 ambulatory blood pressure monitor according to the Association for the Advancement of Medical Instrumentation criteria and the International Protocol. Clin Exp Hypertens 2010; 32:523–527.
32. Li Y, Wei F-F, Thijs L, Boggia J, Asayama K, Hansen TW, et al. Ambulatory hypertension subtypes and 24-hour systolic and diastolic blood pressure as distinct outcome predictors in 8341 untreated people recruited from 12 populations. Circulation 2014; 130:466–474.
33. Kohara K, Jiang Y, Igase M, Takata Y, Fukuoka T, Okura T, et al. Postprandial hypotension is associated with asymptomatic cerebrovas- cular damage in essential hypertensive patients. Hypertension 1999; 33:565–568.
34. Ingelsson E, Bjo¨rklund-Bodega˚ rd K, Lind L, A¨ rnlo¨v J, Sundstro¨m J.Diurnal blood pressure pattern and risk of congestive heart failure. JAMA 2006; 295:2859.
35. Inoue R, Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, et al. Predicting stroke using 4 ambulatory blood pressure monitoring-de- rived blood pressure indices. Hypertension 2006; 48:877–882.
36. Bombelli M, Fodri D, Toso E, Macchiarulo M, Cairo M, Facchetti R, et al. Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white popula- tion. Hypertension 2014; 64:943–950.
37. Juhanoja EP, Niiranen TJ, Johansson JK, Puukka PJ, Thijs L, Asayama K, et al. Outcome-driven thresholds for increased home blood pressure variability. Hypertension 2017; 69:599–607.
38. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53:982–992.
39. DeFilippis AP, Kramer HJ, Katz R, Wong ND, Bertoni AG, Carr J, et al. Association between coronary artery calcification progression and microalbuminuria: the MESA study. JACC Cardiovasc Imaging 2010; 3:595–604.
40. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159:702–706.
41. Budoff MJ, Young R, Burke G, Jeffrey Carr J, Detrano RC, Folsom AR, et al. Ten-year association of coronary artery calcium with atheroscle- rotic cardiovascular disease (ASCVD) events: the multiethnic study of atherosclerosis (MESA). Eur Heart J 2018; 39:2401–2408.
42. Greenland P. Coronary artery calcium score combined with Framingham scoreforriskpredictioninasymptomaticindividuals. JAMA 2004; 291:210.
43. Clavel M-A, Pibarot P, Messika-Zeitoun D, Capoulade R, Malouf J, Aggarwal SR, et al. Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis. J Am Coll Cardiol 2014; 64:1202–1213.
44. Jensky NE, Criqui MH, Wright MC, Wassel CL, Brody SA, Allison MA. Blood pressure and vascular calcification. Hypertension 2010; 55:990– 997.
45. Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? Circulation 2001; 103:1245–1249.
46. Wei Y-C, George NI, Chang C-W, Hicks KA. Assessing sex differ- ences in the risk of cardiovascular disease and mortality per incre- ment in systolic blood pressure: a systematic review and meta- analysis of follow-up studies in the united states. PLoS One 2017; 12: e0170218.
47. Yano Y, Reis JP, Tedla YG, Goff DC, Jacobs DR, Sidney S, et al. Racial differences in associations of blood pressure components in young adulthood with Incident cardiovascular disease by middle age. JAMA Cardiol 2017; 2:381.
48. Liao R, Wang L, Li J, Sun S, Xiong Y, Li Y, et al. Vascular calcification is associated with Wnt-signaling pathway and blood pressure variability in chronic kidney disease rats. Nephrology (Carlton) 2020; 25:264–272.
49. Hisamatsu T, Miura K, Ohkubo T, Arima H, Fujiyoshi A, Satoh A, et al. Home blood pressure variability and subclinical atherosclerosis in multiple vascular beds: a population-based study. J Hypertens 2018; 36:2193–2203.
50. Sasaki S, Yoneda Y, Fujita H, Uchida A, Takenaka K, Takesako T, et al. Association of blood pressure variability with induction of atheroscle- rosis in cholesterol-fed rats. Am J Hypertens 1994; 7:453–459.
51. Chappell DC, Varner SE, Nerem RM, Medford RM, Alexander RW. Oscillatory shear stress stimulates adhesion molecule expression in cultured human endothelium. Circ Res 1998; 82:532–539.
52. De Keulenaer GW, Chappell DC, Ishizaka N, Nerem RM, Alexander RW, Griendling KK. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state. Circ Res 1998; 82:1094–1101.
53. Soulis JV, Giannoglou GD, Chatzizisis YS, Farmakis TM, Giannakoulas GA, Parcharidis GE, et al. Spatialandphasic oscillationofnon-Newtonian wall shear stress in human left coronary artery bifurcation: an insight to atherogenesis. Coron Artery Dis 2006; 17:351–358.
54. Leary AC, Donnan PT, Macdonald TM, Murphy MB. The influence of physical activity on the variability of ambulatory blood pressure. Am J Hypertens 2000; 13:1067–1073.
55. Parati G, Ochoa JE, Lombardi C, Bilo G. Blood pressure variability: assessment, predictive value, and potential as a therapeutic target. Curr Hypertens Rep 2015; 17:537.
論文の公開元へ
